Woodinville biotech lands $6M with plans to raise more, filing shows

Woodinville-based biotech Nortis has raised $6 million in equity funding and is seeking to raise an additional $3.5 million.

Nortis focuses on “organ-on-chip” technology and hopes to create the 21st century gold standard for the preclinical testing of drugs and vaccines to accelerate the discovery and introduction of new therapies.

The company currently has open roles in human resources, biomanufacturing and more.

READ THE STORY at Seattle Inno»